Acute Corneal Transplant Rejection After COVID-19 Vaccination
Acute Corneal Transplant Rejection After COVID-19 Vaccination
Amar P Shah 1, Daliya Dzhaber 1, Kenneth R Kenyon 2, Kamran M Riaz 3, Dean P Ouano 4, Ellen H Koo 1
Affiliations expand
- PMID: 34620770
- DOI: 10.1097/ICO.0000000000002878
Abstract
Purpose: The purpose of this report was to describe 4 cases of acute corneal transplant rejection occurring in association with coronavirus disease 2019 (COVID-19) mRNA vaccination.
Methods: Four patients with prior keratoplasty developed presumed immunologic rejection after the mRNA-1273 vaccination for coronavirus 2 (SARS-CoV-2). Case 1 had received Descemet membrane endothelial keratoplasty 6 months ago and presented with endothelial graft rejection 3 weeks after the first vaccine dose. Case 2 had undergone penetrating keratoplasty 3 years previously and presented with acute endothelial rejection 9 days after the second vaccine dose. Case 3 had prior Descemet stripping automated endothelial keratoplasty (DSAEK) and began experiencing symptoms of endothelial graft rejection 2 weeks after the second vaccine dose. Case 4 presented with endothelial rejection of the penetrating keratoplasty graft 2 weeks after the second vaccine dose.
Results: Frequent topical corticosteroids alone were initiated in all 4 cases. In case 1, the endothelial rejection line appeared fainter with improvement in visual acuity and corneal edema 5 weeks after diagnosis. Case 2 experienced complete resolution of corneal stromal edema and rejection line 6 weeks after diagnosis. Cases 3 and 4 have both experienced initial improvement with steroid treatment as well.
Conclusions: These cases suggest acute corneal endothelial rejection may occur soon after either dose of the COVID-19 mRNA vaccine. Prompt initiation of aggressive topical steroid therapy may result in complete resolution of clinical signs and symptoms. Further studies are needed to elucidate the causal mechanism of corneal graft rejection after COVID-19 vaccination.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
Similar articles
- Acute Corneal Transplant Rejection After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccination.Yu S, Ritterband DC, Mehta I.Cornea. 2022 Feb 1;41(2):257-259. doi: 10.1097/ICO.0000000000002886.PMID: 34690266
- Five Cases of Corneal Graft Rejection After Recent COVID-19 Vaccinations and a Review of the Literature.Molero-Senosiain M, Houben I, Savant S, Savant V.Cornea. 2022 May 1;41(5):669-672. doi: 10.1097/ICO.0000000000002980.PMID: 35383622 Review.
- Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine.Phylactou M, Li JO, Larkin DFP.Br J Ophthalmol. 2021 Jul;105(7):893-896. doi: 10.1136/bjophthalmol-2021-319338. Epub 2021 Apr 28.PMID: 33910885 Free PMC article.
- Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: A case report.Parmar DP, Garde PV, Shah SM, Bhole PK.Indian J Ophthalmol. 2021 Dec;69(12):3757-3758. doi: 10.4103/ijo.IJO_2515_21.PMID: 34827040 Free PMC article.
- Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty: survival, rejection risk, and visual outcome.Mitry D, Bhogal M, Patel AK, Lee BS, Chai SM, Price MO, Price FW Jr, Jun AS, Aldave AJ, Mehta JS, Busin M, Allan BD.JAMA Ophthalmol. 2014 Jun;132(6):742-9. doi: 10.1001/jamaophthalmol.2014.352.PMID: 24763830
Cited by
- Presumably Corneal Graft Rejection after COVID-19 Vaccination.Mohammadzadeh M, Hooshmandi S, Jafari M, Hassanpour K.Case Rep Ophthalmol. 2022 Jul 15;13(2):562-569. doi: 10.1159/000525631. eCollection 2022 May-Aug.PMID: 36160489 Free PMC article.
- Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis.Alhumaid S, Rabaan AA, Dhama K, Yong SJ, Nainu F, Hajissa K, Dossary NA, Alajmi KK, Saggar AEA, AlHarbi FA, Aswany MB, Alshayee AA, Alrabiah SA, Saleh AM, Alqarni MA, Gharib FMA, Qattan SN, Almusabeh HM, AlGhatm HY, Almoraihel SA, Alzuwaid AS, Albaqshi MA, Khalaf MAA, Albaqshi YA, Brahim AHA, Al Mutared MM, Al-Helal H, Alghazal HA, Al Mutair A.Vaccines (Basel). 2022 Aug 10;10(8):1289. doi: 10.3390/vaccines10081289.PMID: 36016180 Free PMC article. Review.
- Characteristics and Clinical Ocular Manifestations in Patients with Acute Corneal Graft Rejection after Receiving the COVID-19 Vaccine: A Systematic Review.Fujio K, Sung J, Nakatani S, Yamamoto K, Iwagami M, Fujimoto K, Shokirova H, Okumura Y, Akasaki Y, Nagino K, Midorikawa-Inomata A, Hirosawa K, Miura M, Huang T, Morooka Y, Kuwahara M, Murakami A, Inomata T.J Clin Med. 2022 Aug 2;11(15):4500. doi: 10.3390/jcm11154500.PMID: 35956115 Free PMC article. Review.
- Cataracts in setting of multisystem inflammation after COVID-19 vaccination.Kim DH, Hsu D, Li Y, Sulewski ME.Am J Ophthalmol Case Rep. 2022 Sep;27:101654. doi: 10.1016/j.ajoc.2022.101654. Epub 2022 Jul 7.PMID: 35818371 Free PMC article.
- Acute corneal allograft rejection following SARS-CoV-2 vaccination-A systematic review.Moura-Coelho N, Cunha JP, Papa-Vettorazzi R, Gris Ó, Güell JL.Acta Ophthalmol. 2022 Jul 4:10.1111/aos.15211. doi: 10.1111/aos.15211. Online ahead of print.PMID: 35781792 Free PMC article. Review.
References
- Johns Hopkins University & Medicine Coronavirus Resource Center. Available at: https://coronavirus.jhu.edu/. Accessed April 12, 2021.